Attributes | Values |
---|
rdf:type
| |
Description
| - The reactions of potassium bis(oxalato)platinate dihydrate with two molar equivalents of the potent adenine-based cyclin-dependent kinase inhibitor 2-(1-ethyl-2-hydroxyethylamino)-N6-(benzyl)-9-isopropyladenine (Roscovitine: Ros) and its benzyl-substituted analogues were performed and the [Pt(ox)(Ros)(2)] 3/4 H2O (1), [Pt(ox)(2OMeRos)(2)] H2O (2), (Pt(ox)(3OMeR-os)(2)] 1/2H(2)O (3) and [Pt(ox)(4OMeRos)(2)] 3/4 H2O (4) platinum(II) oxalato complexes were obtained. In vitro cytotoxic activity of the complexes against ovarian carcinoma (A2780), cisplatin resistant ovarian carcinoma (A2780cis). malignant melanoma (G-361), lung carcinoma (A549). cervix epitheloid carcinoma (HeLa). breast adenocarcinoma (MCF7) and osteosarcoma (HOS) human cancer cell lines was evaluated.
- The reactions of potassium bis(oxalato)platinate dihydrate with two molar equivalents of the potent adenine-based cyclin-dependent kinase inhibitor 2-(1-ethyl-2-hydroxyethylamino)-N6-(benzyl)-9-isopropyladenine (Roscovitine: Ros) and its benzyl-substituted analogues were performed and the [Pt(ox)(Ros)(2)] 3/4 H2O (1), [Pt(ox)(2OMeRos)(2)] H2O (2), (Pt(ox)(3OMeR-os)(2)] 1/2H(2)O (3) and [Pt(ox)(4OMeRos)(2)] 3/4 H2O (4) platinum(II) oxalato complexes were obtained. In vitro cytotoxic activity of the complexes against ovarian carcinoma (A2780), cisplatin resistant ovarian carcinoma (A2780cis). malignant melanoma (G-361), lung carcinoma (A549). cervix epitheloid carcinoma (HeLa). breast adenocarcinoma (MCF7) and osteosarcoma (HOS) human cancer cell lines was evaluated. (en)
|
Title
| - Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity
- Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity (en)
|
skos:prefLabel
| - Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity
- Roscovitine-based CDK inhibitors acting as N-donor ligands in the platinum(II) oxalato complexes: Preparation, characterization and in vitro cytotoxicity (en)
|
skos:notation
| - RIV/61989592:15310/10:10213187!RIV11-MSM-15310___
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15310/10:10213187
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Multinuclear NMR; CDK inhibitors; Cytotoxicity; Oxalate; Platinum(II) complexes (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - FR - Francouzská republika
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - European Journal of Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Dvořák, Zdeněk
- Trávníček, Zdeněk
- Vrzal, Radim
- Štarha, Pavel
- Popa, Igor
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |